BI
Biocept, Inc.
BIOCQ · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $525.0
P/E Ratio -
Div. Yield -
ROE -
Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 7.52%
Rev. growth 67.24%
FCF growth N/A
Profitability
0 /100
Weak Op. margin 123.69%
Gross margin 9.99%
FCF margin 54.51%
Quality
15 /100
Poor Asset turnover 0.84x
ROIC 117.56%
ROA 103.93%
Debt
62 /100
Moderate Int. coverage -100.94x
Debt/Equity 1.37x
Net debt/EBITDA 0.03x
Stability
1 /100
Unstable EPS volatility 564.88%
Beta 3.98x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BIOCQ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Soon Kap Hahn
Employees
50
Headquarters
San Diego
Evenimente viitoare
24 NOV.
Earnings
Upcoming earnings report